Pyrazolopyrimidines for treatment of CNS disorders
US6051578A · kind A · utility
12Cited by
8References
28Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 10, 1998 |
| Grant date | Apr 18, 2000 |
| Priority date | — |
| Expiry date | Sep 10, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/519
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of pyrazolopyrimidines and pyrrolopyrimidine of, respectively, the general formula ##STR1## wherein A, X, R.sup.3, R.sup.4 and R.sup.5 are as defined below, and the pharmaceutically acceptable salts of such compounds, to treat, prevent or inhibit certain neuronal and other disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.